Sphingolipidoses

7,337 views 22 slides Jun 18, 2016
Slide 1
Slide 1 of 22
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22

About This Presentation

sphingolipidoses for under graduate medical students


Slide Content

Sphingolipidoses Dr.S.Sethupathy , M.D., Ph.D ., Department of Biochemistry, Rajah Muthiah Medical College, Annamalai University

Sphingolipids The sphingolipids a complex range of lipids in which fatty acids are linked via amide bonds to a long-chain base or sphingoid . They are also found in a few bacterial genera - Sphingomonas   and   Sphingobacterium .

Globoside

PAPS synthase

Lysosomal storage diseases The lysosomal storage diseases are a rare class of neurometabolic disorders. Metabolites of complex lipids accumulate within neurons. Mostly autosomal recessive fashion For genetic counseling and for monitoring future pregnancies.

Sphingolipidoses They are characterized by a progressive degenerative disease of the nervous system, with blindness, dementia, epilepsy, ataxia, paralysis, and hyperreflexia . A cherry-red spot at the macula and optic atrophy are the most common signs Ophthalmologic examination - an important clue to the diagnosis.

Cherry red spot

Gangliosides Gangliosides are important constituents of gray matter . They are glycosphingolipids that contain sialic acid in the oligosaccharide chain. The metabolism of ganglioside involves the removal of the terminal galactose to convert G M1 -ganglioside to G M2 -ganglioside. G M2 -ganglioside is then hydrolyzed to G M3 -ganglioside by the removal of N- acetylgalactosamine .

D.Blue –GLU, L.Blue - sialic acid, W- NAcGal , Y- Gal

Gangliosidoses They are neuronal lipid storage disorders due to deficiencies of certain lysosomal hydrolases . Autosomal recessive inheritance Progressive mental and motor deterioration Due to the storage of G M1 - or G M2 -ganglioside in neurons.

Prognosis Lysosomal storage diseases are ultimately fatal There is no effective treatment . Almost all the disorders diagnosed by enzyme analysis . Leukocytes and cultured skin fibroblasts or serum can be assayed for enzyme activity Prenatal diagnosis is also possible.

Thank you
Tags